Posts Tagged ‘Biotechnology’
March 26th by Todd Shriber
March 25th by Todd Shriber
In what looks like a sequel to March 2014, high-flying biotechnology stocks and exchange traded...
March 23rd by Paul Weisbruch, Street One Financial
Biotech stocks have had a very interesting past twenty four hours of trading, and the action seems...
March 20th by Tom Lydon
Direxion, the second-largest issuer of leveraged exchange traded funds, has filed plans with the...
March 20th by Todd Shriber
Shares of Biogen Idec (NasdaqGS: BIIB), one of the largest U.S. biotechnology companies, are up 7%...
March 19th by Tom Lydon
The exchange traded fund industry has quickly accumulated over $2 trillion in assets under...
March 17th by Todd Shriber
Not that they need the help, but count biotechnology exchange traded funds among the industry ETFs...
March 10th by Todd Shriber
On the heels of last week’s news that AbbVie (NYSE: ABBV) will acquire cancer treatments maker...